Prevention of vertical HIV transmission
Authors:
- Christoph RudinCRChristoph Rudin
- Claire-Anne SiegristCSClaire-Anne Siegrist
- Claire-Anne WylerCWClaire-Anne Wyler
- Kurt BiedermannKBKurt Biedermann
- Urs LauperULUrs Lauper
- Olivier IrionOIOlivier Irion
- Jörg SchüpbachJSJörg Schüpbach
- David NadalDNDavid Nadal
- 1 January 1998
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 12 (2) , 205-210
Abstract
To study the effect of elective Cesarean section and zidovudine prophylaxis on vertical HIV transmission. Prospective study. Obstetric and paediatric clinics in Switzerland. Children of mothers with HIV infection identified before or at delivery. Routine use of elective Cesarean section for HIV-infected parturients by some Swiss centres since 1985. National recommendation for zidovudine prophylaxis in mid-1994. HIV infection status of children. In a cohort of 494 children born at least 6 months before the analysis date, 67 out of 414 children with known infection status were found to be infected, giving an overall transmission rate of 16.2% [95% confidence interval (CI), 13.0-18.51. Elective Cesarean section with intact membranes and without previous labour was associated with a lower transmission rate of 6% [odds ratio (OR), 0.29; 95% CI, 0.12-0.70; P = 0.006 versus other delivery modes]. Transmission rate was intermediate after spontaneous delivery or non-elective Cesarean section (18%), and higher after obstetric interventions (27%; test for trend, P < 0.001). Since mid-1994, 78% of all women with registered pregnancies have received some form of zidovudine prophylaxis. Transmission rate was reduced from 17 to 7% after any zidovudine exposure (OR, 0.4; 95% CI, 0.11-1.41). Combined use of elective Cesarean section and zidovudine resulted in a 0% transmission rate (none out of 31), compared with 8% (seven out of 86) after elective Cesarean section without zidovudine, 17% (four out of 24) after zidovudine alone, and 20% (55 out of 271) after no intervention. Elective Cesarean section and zidovudine prophylaxis appear to have an additive effect in the prevention of vertical HIV transmission.Keywords
This publication has 12 references indexed in Scilit:
- Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to InfantNew England Journal of Medicine, 1996
- Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohortsAmerican Journal of Obstetrics and Gynecology, 1996
- Cesarean Deliveries and Maternal-Infant HIV Transmission: Results from a Prospective Study in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral loadJAMA, 1996
- Effects of Zidovudine Use During Pregnancy on Resistance and Vertical Transmission of Human Immunodeficiency Virus Type 1Clinical Infectious Diseases, 1995
- Mother to child transmission of zidovudine-resistant HIV-1The Lancet, 1994
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Sensitive Detection and Early Prognostic Significance of p24 Antigen in Heat-Denatured Plasma of Human Immunodeficiency Virus Type 1-Infected InfantsThe Journal of Infectious Diseases, 1994
- Caesarean section and risk of vertical transmission of HIV-1 infectionThe Lancet, 1994
- Epidemiology of vertically transmitted HIV-1 infection in Switzerland: Results of a nationwide prospective studyEuropean Journal of Pediatrics, 1992